Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Accenture
Chubb
Julphar
McKesson
Deloitte
Federal Trade Commission
Fuji
Mallinckrodt

Generated: May 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: duloxetine hydrochloride

« Back to Dashboard

duloxetine hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company N 0002-3235-60
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company N 0002-3240-30
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company N 0002-3240-90
Lilly CYMBALTA duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 021427 NDA Eli Lilly and Company N 0002-3270-04
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Healthtrust
Argus Health
Merck
Baxter
Cantor Fitzgerald
Deloitte
Mallinckrodt
Accenture